ArticleKidney diseases (Basel, Switzerland)2021

Smad3-Targeted Therapy Protects against Cisplatin-Induced AKI by Attenuating Programmed Cell Death and Inflammation via a NOX4-Dependent Mechanism.

Qin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.